Literature DB >> 9689202

Changes in reproductive hormones and sex hormone-binding globulin in a group of postmenopausal women measured over 10 years.

M R Jiroutek1, M H Chen, C C Johnston, C Longcope.   

Abstract

OBJECTIVE: As part of a study on hormones and bone density in older women, we measured a number of steroid and polypeptide hormones at 4- to 6-month intervals in 32 women over a 10-year period.
DESIGN: All women were postmenopausal during this time and all measurements from 12 months after the menopause to the end were used in the analysis. To determine whether there was a significant trend in steroid or polypeptide hormones over the years, the data were analyzed by random coefficient linear regression against number of months since menopause.
RESULTS: There was no significant trend in the concentrations of estrone, estrone sulfate, dehydroepiandrosterone, and follicle stimulating hormone. There was a significant decline in the concentrations of estradiol, dihydrotestosterone, dehydroepiandrosterone sulfate, and luteinizing hormone. There was a rise in the levels of androstenedione and testosterone.
CONCLUSIONS: The changes in the concentration of sex hormone-binding globulin could be fitted to a quadratic equation with an initial rise in the concentration followed by a decline. Thus, the trend in hormone concentrations shows no set pattern with aging in the postmenopausal years.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9689202

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  10 in total

Review 1.  Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.

Authors:  Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-01

Review 2.  Vascular effects of estrogenic menopausal hormone therapy.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Rev Recent Clin Trials       Date:  2012-02

Review 3.  Postmenopausal hypertension.

Authors:  Licy L Yanes; Jane F Reckelhoff
Journal:  Am J Hypertens       Date:  2011-04-21       Impact factor: 2.689

4.  Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.

Authors:  Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2013-10-04       Impact factor: 5.858

Review 5.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

6.  Chronic Blockade of the Androgen Receptor Abolishes Age-Dependent Increases in Blood Pressure in Female Growth-Restricted Rats.

Authors:  John Henry Dasinger; Suttira Intapad; Benjamin R Rudsenske; Gwendolyn K Davis; Ashley D Newsome; Barbara T Alexander
Journal:  Hypertension       Date:  2016-04-25       Impact factor: 10.190

Review 7.  Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens.

Authors:  Maurand Cappelletti; Kim Wallen
Journal:  Horm Behav       Date:  2015-11-14       Impact factor: 3.587

8.  Testosterone, sex hormone-binding globulin and free androgen index among adult women: chronological and ovarian aging.

Authors:  M F R Sowers; H Zheng; D McConnell; B Nan; C A Karvonen-Gutierrez; J F Randolph
Journal:  Hum Reprod       Date:  2009-06-11       Impact factor: 6.918

Review 9.  Sex Hormones, Sleep, and Memory: Interrelationships Across the Adult Female Lifespan.

Authors:  Yasmin A Harrington; Jeanine M Parisi; Daisy Duan; Darlynn M Rojo-Wissar; Calliope Holingue; Adam P Spira
Journal:  Front Aging Neurosci       Date:  2022-07-14       Impact factor: 5.702

10.  mTOR inhibitor improves testosterone-induced myocardial hypertrophy in hypertensive rats.

Authors:  Jianshu Chen; Jing Yu; Ruowen Yuan; Ningyin Li; Caie Li; Xiaofang Zhang
Journal:  J Endocrinol       Date:  2022-01-31       Impact factor: 4.286

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.